Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Antidepressant
AN-788
Другие языки:

    AN-788

    Подписчиков: 0, рейтинг: 0
    AN-788
    Clinical data
    Other names NSD-788
    Drug class Monoamine reuptake inhibitor; Serotonin–dopamine reuptake inhibitor
    Identifiers
    CAS Number

    AN-788, also known as NSD-788, is an experimental medication which was originated by NeuroSearch and is under development by Aniona and Saniona for the treatment of major depressive disorder. It was also under development for anxiety disorders, but development for this indication was discontinued. The drug acts as a serotonin–dopamine reuptake inhibitor (SDRI). As of November of 2018, it is in an agreement for phase II clinical trials for major depressive disorder.

    See also



    Новое сообщение